CTLL assay: Comparison of two methods for IL-2 determination

Folia Biologica

Volumn 43, Issue 1, 1997, Pages 45-47

  Indrova M ^a   Pajtasz Piasecka, E ^b   Radzikowski, C ^b   Bubenik J ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

3H thymidine assay; IL 2; MTT assay

Indexed keywords

INTERLEUKIN 2; THYMIDINE; TRITIUM;

ARTICLE; ASSAY; COLORIMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DNA TRANSFECTION; HUMAN; HUMAN CELL; ISOTOPE LABELING; NITROBLUE TETRAZOLIUM TEST; PROTEIN DETERMINATION; TECHNIQUE;

TRITIUM;

EID: 0031025247     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Berg, K., Hansen, M. B., Nielsen, S. E. (1990) A new sensitive bioassay for precise quantification of interferon activity as measured via the mitochondrial dehydrogenase function in cells (MTT method). APMIS 98, 156-162.
2. Bubeník, J. (1993) IL-2 and gene therapy of cancer (Review). Int. J. Oncol. 2, 1049-1051.
3. Bubeník, J., Indrová, M., Perlmann, P., Berzins, K., Mach, O., Kraml, J., Toulcová, A. (1985) Tumour inhibitory effects of TCGF (IL2)-containing preparations. Cancer Immunol. Immunother. 19, 57-61.
4. Bubeník, J., Indrová, M., Němečková, S., Malkovský, M., von Broen, B., Pálek, V., Anderlíková, J. (1978) Solubilized tumour-associated antigens of methylcholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph node cells, macrophage electrophoretic mobility assay and transplantation tests. Int. J. Cancer 21, 348-355.
5. Bubeník, J., Indrová, M., Šímová, J., Kypěnová, H., Bubeníková, D., Doležalová, K. (1984) Phorbol myristate acetate-stimulated production of interleukin 2 by T-cell lymphoma and constitutive production by derived hybridomas. Neoplasma 31, 497-505.
6. Bubeník, J., Šímová, J., Jandlová, T. (1989/1990) Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2. Immunol. Lett. 23, 287-292.
7. Forni, G., Giovarelli, M., Cavallo, F., Consalvo, M., Allione, A., Modesti, A., Musiani, P., Colombo, M. P. (1993) Cytokine-induced immunogenicity: from exogenous cytokines to gene therapy. J. Immunother. 14, 253-257.
8. 3H-thymidine incorporation with MTT-and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. J. Immunol. Methods 187, 85-93.
9. Gillis, S., Ferm, M. M., Ou, W., Smith, K. A. (1978) T-cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120, 2027-2032.
10. Karasuyama, H., Melchers, F. (1988) Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5 using modified cDNA expression vectors. Eur. J. Immunol. 18, 97-104.
11. Mosmann, T. (1988) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
12. Pajtasz-Piasecka, E., Glazman-Kusnierczyk, H., Salwa, J., Konarski, L., Radzikowski, C. (1995) Growth inhibition of transplantable tumours in mice by mIL-2-secreting murine plasmocytoma cells used alone or in combination with a cytostatic agent. Arch. Immunol. Ther. Exper. 43, 281-292.
13. Smith, K. A. (1980a) T-cell growth factor. Immunol. Rev. 51, 337-357.
14. Smith, K. A. (1980b) Continuous cytotoxic T-cell lines. In: Contemporary Topics in Immunobiology, ed. Warner, N. L., pp. 139-155, Plenum Press, New York.